Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target. [electronic resource]
Producer: 20130211Description: 337-46 p. digitalISSN:- 1873-7064
- Animals
- Antidepressive Agents -- adverse effects
- Cognition Disorders -- chemically induced
- Depressive Disorder, Major -- drug therapy
- Excitatory Amino Acid Agonists -- adverse effects
- Excitatory Amino Acid Antagonists -- pharmacology
- GABAergic Neurons -- drug effects
- Hippocampus -- drug effects
- Humans
- Interneurons -- drug effects
- Molecular Targeted Therapy
- Nerve Tissue Proteins -- agonists
- Nootropic Agents -- pharmacology
- Receptors, Metabotropic Glutamate -- agonists
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.